Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Sustainable, Profitable Mineral Development for Today…and Tomorrow

(Click image to play video) Environmental sustainability while maintaining profitability and shareholder value are the hallmarks of any modern, forward-thinking company. This is especially the case in the critical minerals space. Avalon Advanced Materials Inc...
Dave Jackson | January 27, 2021 |

BP, Exxon, Shell, Saturn Oil & Gas - Crude oil up to USD 100 in May?

In recent weeks, even experienced investors have learned a lot about the oil market. When the price of WTI slipped into the red in April 2020, this was a first in the history of black gold. On the one hand, the oversupply of producers put pressure on prices, but speculators al...
Mario Hose | May 6, 2020 |

Precious 'Mettle'

"Mettle"—the ability to cope with difficulties or to face a demanding situation in a spirited and resilient way. Given the performance of my beloved Gold and Gold Miners in the past month, could there have ever been a more fitting word describing our sector than in the ...
Streetwise Reports | July 6, 2019 |

Fundamentals in Supply and Demand Will Bolster Market for Rare Earth Elements

Rare earth elements (REEs) have been in the geopolitical spotlight for much of the year. Many, myself included, are surprised that the combination of severe trade tensions between the U.S. and China, strong growth in wind farm installations (wind farms use lots of REE m...
Streetwise Reports | September 23, 2019 |

Is ValOre Primed for PGM’s Perfect Storm?

It has all the makings of a perfect storm of opportunity, in spite of the recent onset of a long-awaited cyclical bear market for North America’s capital markets. A surging market for platinum prices and other platinum group metals (PGMs) over the past sev...
Marc Davis | March 31, 2020 |

Junior Royalty Company Wants to Be a Major

Ely Gold aims to emulate the early years of today's royalty majors. Ely Gold Royalties Inc. (ELY:TSX.V; ELYGF:OTCQB; I4U:FSE) features a unique business model: in addition to purchasing royalties outright, it engages in royalty generation, which is acquiring prope...
Streetwise Reports | June 19, 2020 |

A Unique Solution to Meet Lithium’s Supply Gap

(Chart via Benchmark Mineral Intelligence. Click to enlarge.) A lithium supply gap? There is demand growth, but it is stifled by limited investments in mines and converters. A key theme for mining investors in 2021 revolves around the acceleration in demand fo...
Stockhouse Editorial | January 29, 2021 |

Biopharma's Early Data Show Immunotherapy's Efficacy in Ovarian Cancer

The "encouraging" data for this drug candidate as a monotherapy is the focus of an H.C. Wainwright & Co. report. In a March 26 research note, analyst Joseph Pantginis reported that IMV Inc.'s (IMV:TSX; IMMVD:OTCQX) preliminary monotherapy data confirmed the efficacy o...
Streetwise Reports | April 1, 2019 |

California-Based Biopharma Signs Licensing Deal for Acquired Asset

The transaction details and the drug platform's potential are addressed in an H.C. Wainwright & Co. report. In May 21 research note, H.C. Wainwright & Co. analyst Joseph Pantginis reported that Ligand Pharmaceuticals Inc. (LGND:NASDAQ) signed a licensing d...
Streetwise Reports | May 27, 2019 |

New Data Could Drive Use of Pancreatic Cancer Early Detection Test

The recent results and their implications are provided in an H.C. Wainwright & Co. report. In an Oct. 25 research note, H.C. Wainwright & Co. analyst Yi Chen reported that newly compiled data support the clinical utility of Interpace Diagnostics Group Inc.'s (IDXG:NA...
Streetwise Reports | October 30, 2019 |
1 2 3 4 5 6 7 8 9 10 ...